Comparing Bacillus Calmette-Guérin (BCG) strains in convalescent COVID-19 patients. Supplementary tables

<strong>Supplementary Table 1.</strong> COVID-19 symptom progression. P-Value is calculated using Fisher’s exact test comparing BCG-R (Russia) to BCG-B (Brazil). Placebo data is provided for comparison. Lesion type is compared between two groups using Fisher’s exact test showing a slightly higher probability of pustule formation during the first week in the BCG-Brazil group. <br> Supplementary Table 2. There are six trials comparing effect of various strains of BCG including: BCG-Japan, BCG-Russia, BCG-Russia-I (Serum Institute of India), BCG-Denmark 1331, BCG-Tice, BCG- Connaught, BCG-Tokyo-172, BCG-Denmark culture (SSI), on Heterologous Immunity, Infant Morbidity, Infant Mortality, Trained Immunity, Vaccine Reaction, and Bladder Urothelial Carcinoma. <br> <br>